Literature DB >> 32678800

Drug Selection for Treating Hypertension in Dialysis Patients: More to Consider than BP-Lowering Potency.

Tariq Shafi1, Dana C Miskulin2.   

Abstract

Entities:  

Keywords:  antihypertensive drug class; dialysis; hypertension

Year:  2020        PMID： 32678800      PMCID： PMC7409756          DOI： 10.2215/CJN.09910620

Source DB:  PubMed          Journal:  Clin J Am Soc Nephrol        ISSN： 1555-9041            Impact factor:   8.237


× No keyword cloud information.
  10 in total

1.  In-center hemodialysis six times per week versus three times per week.

Authors:  Glenn M Chertow; Nathan W Levin; Gerald J Beck; Thomas A Depner; Paul W Eggers; Jennifer J Gassman; Irina Gorodetskaya; Tom Greene; Sam James; Brett Larive; Robert M Lindsay; Ravindra L Mehta; Brent Miller; Daniel B Ornt; Sanjay Rajagopalan; Anjay Rastogi; Michael V Rocco; Brigitte Schiller; Olga Sergeyeva; Gerald Schulman; George O Ting; Mark L Unruh; Robert A Star; Alan S Kliger
Journal:  N Engl J Med       Date:  2010-11-20       Impact factor: 91.245

2.  Out-of-hemodialysis-unit blood pressure is a superior determinant of left ventricular hypertrophy.

Authors:  Rajiv Agarwal; Neva J Brim; Jothiharan Mahenthiran; Martin J Andersen; Chandan Saha
Journal:  Hypertension       Date:  2005-12-12       Impact factor: 10.190

3.  A randomized controlled trial of the effect of spironolactone on left ventricular mass in hemodialysis patients.

Authors:  Fabian Hammer; Uwe Malzahn; Julian Donhauser; Christoph Betz; Markus P Schneider; Clemens Grupp; Nils Pollak; Stefan Störk; Christoph Wanner; Vera Krane
Journal:  Kidney Int       Date:  2019-01-31       Impact factor: 10.612

Review 4.  Beta-blockers for hypertension.

Authors:  Charles S Wiysonge; Hazel A Bradley; Jimmy Volmink; Bongani M Mayosi; Lionel H Opie
Journal:  Cochrane Database Syst Rev       Date:  2017-01-20

5.  Primary outcomes of the Monitoring in Dialysis Study indicate that clinically significant arrhythmias are common in hemodialysis patients and related to dialytic cycle.

Authors:  Prabir Roy-Chaudhury; Jim A Tumlin; Bruce A Koplan; Alexandru I Costea; Vijay Kher; Don Williamson; Saurabh Pokhariyal; David M Charytan
Journal:  Kidney Int       Date:  2018-02-12       Impact factor: 10.612

6.  Towards improved cardiovascular management: the necessity of combining blood pressure and fluid overload.

Authors:  Peter Wabel; Ulrich Moissl; Paul Chamney; Tomas Jirka; Petr Machek; Pedro Ponce; Petr Taborsky; Ciro Tetta; Nestor Velasco; Jiri Vlasak; Wojciech Zaluska; Volker Wizemann
Journal:  Nephrol Dial Transplant       Date:  2008-05-05       Impact factor: 5.992

7.  Long 3 x 8 hr dialysis: a three-decade summary.

Authors:  Bernard Charra; Charles Chazot; Guillaume Jean; Jean-Marc Hurot; Thierry Vanel; Jean-Claude Terrat; Cyril VoVan
Journal:  J Nephrol       Date:  2003 Nov-Dec       Impact factor: 3.902

8.  A Randomized Trial of Intensive versus Standard Blood-Pressure Control.

Authors:  Jackson T Wright; Jeff D Williamson; Paul K Whelton; Joni K Snyder; Kaycee M Sink; Michael V Rocco; David M Reboussin; Mahboob Rahman; Suzanne Oparil; Cora E Lewis; Paul L Kimmel; Karen C Johnson; David C Goff; Lawrence J Fine; Jeffrey A Cutler; William C Cushman; Alfred K Cheung; Walter T Ambrosius
Journal:  N Engl J Med       Date:  2015-11-09       Impact factor: 91.245

9.  Comparative Efficacy and Safety of BP-Lowering Pharmacotherapy in Patients Undergoing Maintenance Dialysis: A Network Meta-Analysis of Randomized, Controlled Trials.

Authors:  Ahmed M Shaman; Brendan Smyth; Clare Arnott; Suetonia C Palmer; Anastasia S Mihailidou; Meg J Jardine; Martin P Gallagher; Vlado Perkovic; Min Jun
Journal:  Clin J Am Soc Nephrol       Date:  2020-07-16       Impact factor: 8.237

10.  Evaluating the quality of evidence from a network meta-analysis.

Authors:  Georgia Salanti; Cinzia Del Giovane; Anna Chaimani; Deborah M Caldwell; Julian P T Higgins
Journal:  PLoS One       Date:  2014-07-03       Impact factor: 3.240
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.